Were Hedge Funds Right About Chimerix Inc (CMRX)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 866 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds’ and investors’ portfolio positions as of March 31st. In this article we look at what those investors think of Chimerix Inc (NASDAQ:CMRX).
Is
Chimerix Inc (NASDAQ:CMRX) going to take off soon? Prominent investors were in a bullish mood. The number of bullish hedge fund positions improved by 3 lately. Chimerix Inc (NASDAQ:CMRX) was in 16 hedge funds’ portfolios at the end of the first quarter of 2021. The all time high for this statistic is 17. Our calculations also showed that CMRX isn’t among the 30 most popular stocks among hedge funds (click for Q1 rankings). There were 13 hedge funds in our database with
Were Hedge Funds Right About Anterix Inc (ATEX)?
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
Were Hedge Funds Right About Caleres Inc (CAL)?
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
Operator
Greetings, and welcome to the Collegium Pharmaceutical First Quarter 2021 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Alex Dasalla. Please go ahead.
Alex Dasalla
Head of Investor Relations
Welcome to Collegium Pharmaceuticals first quarter 2021 earnings conference call. This is Alex Dasalla, Head of Investor Relations for Collegium. I am joined today by Joe Ciaffoni, our Chief Executive Officer; Paul Brannelly, our Chief Financial Officer; and Scott Dreyer, our Chief Commercial Officer.
Before we begin today s call, we want to remind participants that none of the information presented today is intended to be promotional and that any forward-looking statements made today are made pursuant to the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995. You are cautioned that such forward-looking statements involve risks and uncertainties, including and with